Last updated: 17 June 2024 at 6:57pm EST

William Bertrand Net Worth




The estimated Net Worth of William C Jr Bertrand is at least 1.57 百万$ dollars as of 16 January 2024. Mr. Bertrand owns over 23,589 units of Adaptimmune Therapeutics Plc stock worth over 21,817$ and over the last 9 years he sold ADAP stock worth over 183,298$. In addition, he makes 1,369,510$ as Chief Operating Officer at Adaptimmune Therapeutics Plc.

Mr. Bertrand ADAP stock SEC Form 4 insiders trading

William has made over 16 trades of the Adaptimmune Therapeutics Plc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 23,589 units of ADAP stock worth 16,512$ on 16 January 2024.

The largest trade he's ever made was buying 207,000 units of Adaptimmune Therapeutics Plc stock on 14 December 2020 worth over 142,830$. On average, William trades about 8,401 units every 84 days since 2015. As of 16 January 2024 he still owns at least 20,201 units of Adaptimmune Therapeutics Plc stock.

You can see the complete history of Mr. Bertrand stock trades at the bottom of the page.





William Bertrand biography

William C. Bertrand Jr., Esq., J.D. serves as Chief Operating Officer of the Company. Mr. Bertrand's prior experience includes a 12 year tenure at MedImmune, where he served as its first General Counsel and Chief Compliance Officer, along with holding a variety of operational and corporate strategy roles. He has also formerly served as Executive Vice President, General Counsel for Infinity Pharmaceuticals, Inc., and as Senior Vice President, Acting Chief Operating Officer and General Counsel for Salix Pharmaceuticals, where he remained as General Manager to help finalize the integration of the company's $14 billion acquisition by Valeant Pharmaceuticals in April 2015. He is currently a member of the board of directors of Ardelyx, Inc. (Nasdaq:ARDX). Mr. Bertrand received a J.D. from the University of Wisconsin and a B.S. in biology from Wayne State University.

What is the salary of William Bertrand?

As the Chief Operating Officer of Adaptimmune Therapeutics Plc, the total compensation of William Bertrand at Adaptimmune Therapeutics Plc is 1,369,510$. There are 2 executives at Adaptimmune Therapeutics Plc getting paid more, with James Noble having the highest compensation of 2,821,740$.



How old is William Bertrand?

William Bertrand is 55, he's been the Chief Operating Officer of Adaptimmune Therapeutics Plc since 2017. There are 7 older and 10 younger executives at Adaptimmune Therapeutics Plc. The oldest executive at Adaptimmune Therapeutics Plc is Lawrence Alleva, 70, who is the Non-Executive Independent Director.

What's William Bertrand's mailing address?

William's mailing address filed with the SEC is C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM, MA, 02451.

Insiders trading at Adaptimmune Therapeutics Plc

Over the last 9 years, insiders at Adaptimmune Therapeutics Plc have traded over 40,532,026$ worth of Adaptimmune Therapeutics Plc stock and bought 384,338,252 units worth 527,131,726$ . The most active insiders traders include Forest BaskettScott D SandellAnthony A. Jr. Florence. On average, Adaptimmune Therapeutics Plc executives and independent directors trade stock every 20 days with the average trade being worth of 2,827,332$. The most recent stock trade was executed by Cintia Piccina on 18 June 2024, trading 24,531 units of ADAP stock currently worth 22,814$.



What does Adaptimmune Therapeutics Plc do?

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.



What does Adaptimmune Therapeutics Plc's logo look like?

Adaptimmune Therapeutics Plc logo

Complete history of Mr. Bertrand stock trades at Adaptimmune Therapeutics Plc、Ardelyx Inc、Infinity Pharmaceuticals

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
16 Jan 2024 William C Jr Bertrand
最高執行責任者
販売 23,589 0.70$ 16,512$
16 Jan 2024
20,201
11 Jan 2024 William C Jr Bertrand
最高執行責任者
販売 9,229 0.85$ 7,845$
11 Jan 2024
7,874
17 Jan 2023 William C Jr Bertrand
最高執行責任者
販売 4,440 1.86$ 8,258$
17 Jan 2023
7,264
11 Jan 2023 William C Jr Bertrand
最高執行責任者
販売 8,816 1.72$ 15,164$
11 Jan 2023
8,121
4 Jan 2023 William C Jr Bertrand
最高執行責任者
販売 3,584 1.69$ 6,057$
4 Jan 2023
5,781
18 Jan 2022 William C Jr Bertrand
最高執行責任者
販売 4,368 3.19$ 13,934$
18 Jan 2022
7,336
11 Jan 2022 William C Jr Bertrand
最高執行責任者
販売 6,018 3.55$ 21,364$
11 Jan 2022
3,754
4 Jan 2022 William C Jr Bertrand
最高執行責任者
販売 3,490 4.06$ 14,169$
4 Jan 2022
5,873
2 Jul 2021 William C Jr Bertrand
最高執行責任者
販売 4,375 4.26$ 18,638$
2 Jul 2021
7,329
12 Jan 2021 William C Jr Bertrand
最高執行責任者
販売 2,234 6.15$ 13,739$
12 Jan 2021
3,768
4 Jan 2021 William C Jr Bertrand
最高執行責任者
販売 3,499 5.33$ 18,650$
4 Jan 2021
5,864
14 Dec 2020 William C Jr Bertrand
最高執行責任者
購入する 207,000 0.69$ 142,830$
14 Dec 2020
284,808
14 Jan 2020 William C Jr Bertrand
最高執行責任者
販売 2,397 5.13$ 12,297$
14 Jan 2020
3,605
6 Jan 2020 William C Jr Bertrand
最高執行責任者
販売 3,731 1.20$ 4,477$
6 Jan 2020
5,632
14 Jan 2019 William C Jr Bertrand
最高執行責任者
販売 2,271 5.37$ 12,195$
14 Jan 2019
3,731
17 Dec 2015 William C Jr Bertrand
ディレクター
購入する 5,000 20.00$ 100,000$
17 Dec 2015
5,000


Adaptimmune Therapeutics Plc executives and stock owners

Adaptimmune Therapeutics Plc executives and other stock owners filed with the SEC include: